{
  "guideline": {
    "id": "PA166104938",
    "name": "Annotation of DPWG Guideline for acenocoumarol and VKORC1",
    "source": "DPWG",
    "version": 37,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104938",
    "relatedChemicals": [
      {
        "id": "PA452632",
        "name": "acenocoumarol",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA133787052",
        "name": "vitamin K epoxide reductase complex subunit 1",
        "symbol": "VKORC1"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166299301",
      "name": "Recommendation PA166299301",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA452632",
          "name": "acenocoumarol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061664,
        "html": "<p>Monitoring by the ANTICOAGULATION CLINIC (National INR Monitoring Service):</p>\n<ul>\n<li>recommend to use 50% of the standard initial dose</li>\n</ul>\n<p>OTHERWISE:</p>\n<ul>\n<li>recommend to use 50% of the standard initial dose</li>\n<li>recommend more frequent monitoring of the INR</li>\n</ul>\n"
      },
      "implications": [
        "An INR â‰¥ 6, resulting in an increased risk of bleeding, occurs in 8-12% of these patients during the first weeks of treatment with standard regulation by the Anticoagulation Clinic. The genetic variation increases the sensitivity to acenocoumarol."
      ],
      "lookupKey": {
        "VKORC1": "-1639 AA"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166299299",
      "name": "Recommendation PA166299299",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA452632",
          "name": "acenocoumarol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061662,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The genetic variation results in a reduction of the required dose, but with the current practice of initiating or reviewing treatment this results in little or no increased risk of\nbleeding or excessive anticoagulation."
      ],
      "lookupKey": {
        "VKORC1": "-1639 AG"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166299300",
      "name": "Recommendation PA166299300",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA452632",
          "name": "acenocoumarol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452061663,
        "html": "<p>The guideline does not provide a recommendation for acenocoumarol in patients with the VKORC1 rs9923231 CC genotype (-1639 GG genotype).</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of the -1639 GG genotype on acenocoumarol."
      ],
      "lookupKey": {
        "VKORC1": "-1639 GG"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": "21412232",
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011
    }
  ],
  "version": "2023-12-19-10-38"
}